SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Leon P McLean, Raymond K Cross, Adverse events in IBD: to stop or continue immune suppressant and biologic treatment, Expert Review of Gastroenterology & Hepatology, 2014, 8, 3, 223

    CrossRef

  2. 2
    Elena Nikiphorou, Andra Negoescu, John D. Fitzpatrick, Calum T. Goudie, Andrew Badcock, Andrew J. K. Östör, Anshuman P. Malaviya, Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort, Clinical Rheumatology, 2014, 33, 5, 609

    CrossRef

  3. 3
    Antonio González-Sarrías, Mar Larrosa, María Teresa García-Conesa, Francisco A. Tomás-Barberán, Juan Carlos Espín, Nutraceuticals for older people: Facts, fictions and gaps in knowledge, Maturitas, 2013, 75, 4, 313

    CrossRef

  4. 4
    Vasco Romão, Helena Canhão, João Fonseca, Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?, BMC Medicine, 2013, 11, 1, 17

    CrossRef

  5. 5
    Anna Buchner, Wojciech Blonski, Gary R Lichtenstein, Advances in the Management of Inflammatory Bowel Disease, 2013,

    CrossRef

  6. 6
    Shinichi Kawai, Tsutomu Takeuchi, Kazuhiko Yamamoto, Yoshiya Tanaka, Nobuyuki Miyasaka, Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs—a multicenter, double-blind, parallel-group trial, Modern Rheumatology, 2011, 21, 5, 458

    CrossRef

  7. 7
    Shinichi Kawai, Tsutomu Takeuchi, Kazuhiko Yamamoto, Yoshiya Tanaka, Nobuyuki Miyasaka, Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs—a multicenter, double-blind, parallel-group trial, Modern Rheumatology, 2011, 21, 5, 458

    CrossRef

  8. 8
    Anna M. Buchner, Wojciech Blonski, Gary R. Lichtenstein, Update on the Management of Crohn’s Disease, Current Gastroenterology Reports, 2011, 13, 5, 465

    CrossRef

  9. 9
    Norman T. Ilowite, Ronald M. Laxer, Textbook of Pediatric Rheumatology, 2011,

    CrossRef

  10. 10
    Alyssa K. Johnsen, Michael E. Weinblatt, Rheumatology, 2011,

    CrossRef

  11. 11
    D. Holzinger, M. Frosch, D. Föll, Methotrexat bei der Therapie der juvenilen idiopathischen Arthritis, Zeitschrift für Rheumatologie, 2010, 69, 6, 496

    CrossRef

  12. 12
    S. Prey, C. Paul, Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review, British Journal of Dermatology, 2009, 160, 3
  13. 13
    Alyssa K. Johnsen, Michael E. Weinblatt, Rheumatoid Arthritis, 2009,

    CrossRef

  14. 14
    P. Goldsmith, A. Roach, Methods to enhance the safety of methotrexate prescribing, Journal of Clinical Pharmacy and Therapeutics, 2007, 32, 4
  15. 15
    Stephan Pavy, Arnaud Constantin, Thao Pham, Laure Gossec, Jean-Francis Maillefert, Alain Cantagrel, Bernard Combe, René-Marc Flipo, Philippe Goupille, Xavier Le Loët, Xavier Mariette, Xavier Puéchal, Thierry Schaeverbeke, Jean Sibilia, Jacques Tebib, Daniel Wendling, Maxime Dougados, Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion, Joint Bone Spine, 2006, 73, 4, 388

    CrossRef

  16. 16
    Bruce E. Strober, Kavita Menon, Folate supplementation during methotrexate therapy for patients with psoriasis, Journal of the American Academy of Dermatology, 2005, 53, 4, 652

    CrossRef

  17. 17
    Bruce N. Cronstein, Folic acid and folinic acid supplements and methotrexate therapy: Comment on the article by Morgan et al, Arthritis & Rheumatism, 2005, 52, 4
  18. 18
    P. Harten, Folsäure zur Reduktion der Methotrexat-Toxizität, Zeitschrift für Rheumatologie, 2005, 64, 5, 353

    CrossRef

  19. 19
    G M J Deeming, J Collingwood, M N Pemberton, Methotrexate and oral ulceration, British Dental Journal, 2005, 198, 2, 83

    CrossRef

  20. 20
    Sarah L. Morgan, Joseph E. Baggott, Reply, Arthritis & Rheumatism, 2005, 52, 4
  21. 21
    F. N. Aberra, G. R. Lichtenstein, Review article: monitoring of immunomodulators in inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, 2005, 21, 4
  22. 22
    Sarah L. Morgan, Robert A. Oster, Jeannette Y. Lee, Graciela S. Alarcón, Joseph E. Baggott, The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis, Arthritis & Rheumatism, 2004, 50, 10
  23. 23
    S. de Lathouder, A. H. Gerards, B. A.C. Dijkmans, L. A. Aarden, Two Inhibitors of DNA-Synthesis Lead to Inhibition of Cytokine Production via a Different Mechanism, Nucleosides, Nucleotides and Nucleic Acids, 2004, 23, 8-9, 1089

    CrossRef

  24. 24
    Guidelines for the management of rheumatoid arthritis: 2002 Update , Arthritis & Rheumatism, 2002, 46, 2
  25. 25
    Violeta Mihailovic Vucinic, What is the future of methotrexate in sarcoidosis? A study and review, Current Opinion in Pulmonary Medicine, 2002, 8, 5, 470

    CrossRef

  26. 26
    N. Fathy, Daniel E. Furst, Combination therapy for autoimmune diseases: the rheumatoid arthritis model, Springer Seminars in Immunopathology, 2001, 23, 1-2, 5

    CrossRef

  27. 27
    Annelies E. Van Ede, Roland F. J. M. Laan, Maarten J. Rood, Tom W. J. Huizinga, Mart A. F. J. Van De Laar, Christiaan J. Van Denderen, Toon A. A. Westgeest, Ton C. Romme, Dirk-Jan R. A. M. De Rooij, Marike J. M. Jacobs, Theo M. De Boo, Gert-Jan Van Der Wilt, Johan L. Severens, Margriet Hartman, Paul F. M. Krabbe, Ben A. C. Dijkmans, Ferdinand C. Breedveld, Leo B. A. Van De Putte, Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: A forty-eight–week, multicenter, randomized, double-blind, placebo-controlled study, Arthritis & Rheumatism, 2001, 44, 7
  28. 28
    J.A. Mosquera Martínez, Fármacos con actividad de fondo en patología inflamatoria articular (II), Medicine - Programa de Formación Médica Continuada Acreditado, 2001, 8, 31, 1622

    CrossRef

  29. 29
    John P. Case, Old and New Drugs Used in Rheumatoid Arthritis: A Historical Perspective, American Journal of Therapeutics, 2001, 8, 2, 123

    CrossRef

  30. 30
    Joel M. Kremer, Methotrexate and leflunomide: Biochemicalbasis for combination therapy in the treatment of rheumatoid arthritis, Seminars in Arthritis and Rheumatism, 1999, 29, 1, 14

    CrossRef

  31. 31
    Annelies E. van Ede, Roland F.J.M. Laan, Henk J. Blom, Ronney A. De Abreu, Leo B.A. van de Putte, Methotrexate in rheumatoid arthritis: An updatewith focus on mechanisms involved in toxicity, Seminars in Arthritis and Rheumatism, 1998, 27, 5, 277

    CrossRef

  32. 32
    Lourdes Villalba, Jeanne E. Hicks, Elizabeth M. Adams, Jeffrey B. Sherman, Mark F. Gourley, Richard L. Leff, Bonnie C. Thornton, Suzanne H. Burgess, Paul H. Plotz, Frederick W. Miller, Treatment of refractory myositis: A randomized crossover study of two new cytotoxic regimens, Arthritis & Rheumatism, 1998, 41, 3
  33. 33
    Israeli A. Jaffe, Bruce Cronstein, Antifolate effect of methotrexate: Comment on the article by cronstein, Arthritis & Rheumatism, 1997, 40, 8
  34. 34
    Graciela S. Alarcón, Sarah L. Morgan, Robert W. Simms, C. Kent Kwoh, Larry G. Anderson, Diane M. Erlandson, Jerry M. Greene, Carolee Moncur, James R. O'Dell, Alison J. Partridge, W. Neal Roberts, Mark L. Robbins, Robert A. Yood, Matthew H. Liang, Guidelines for folate supplementation in rheumatoid arthritis patients treated with methotrexate: Comment on the guidelines for monitoring drug therapy, Arthritis & Rheumatism, 1997, 40, 2
  35. 35
    Christopher S. George, Alan E. Lichtin, HEMATOLOGIC COMPLICATIONS OF RHEUMATIC DISEASE THERAPIES, Rheumatic Disease Clinics of North America, 1997, 23, 2, 425

    CrossRef

  36. 36
    Sterling G. West, METHOTREXATE HEPATOTOXICITY, Rheumatic Disease Clinics of North America, 1997, 23, 4, 883

    CrossRef

  37. 37
    James R. O'Dell, METHOTREXATE USE IN RHEUMATOID ARTHRITIS, Rheumatic Disease Clinics of North America, 1997, 23, 4, 779

    CrossRef

  38. 38
    S. Louis Bridges, Larry W. Moreland, PERIOPERATIVE USE OF METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS UNDERGOING ORTHOPEDIC SURGERY, Rheumatic Disease Clinics of North America, 1997, 23, 4, 981

    CrossRef

  39. 39
    Jeffrey B. Shiroky, FRCP(C), THE USE OF FOLATES CONCOMITANTLY WITH LOW-DOSE PULSE METHOTREXATE, Rheumatic Disease Clinics of North America, 1997, 23, 4, 969

    CrossRef

  40. 40
    Ami Schattner, Treatment considerations in early rheumatoid arthritis, Journal of Internal Medicine, 1997, 241, 6
  41. 41
    Rita Jain, Peter E. Lipsky, TREATMENT OF RHEUMATOID ARTHRITIS, Medical Clinics of North America, 1997, 81, 1, 57

    CrossRef

  42. 42
    Guidelines for the management of rheumatoid arthritis, Arthritis & Rheumatism, 1996, 39, 5
  43. 43
    Jan P. Dutz, Vincent C. Ho, Immunosuppressive Agents in Skin Disorders, Clinical Immunotherapeutics, 1996, 5, 4, 268

    CrossRef

  44. 44
    Laurence J. Egan, William J. Sandborn, Methotrexate for Inflammatory Bowel Disease: Pharmacology and Preliminary Results, Mayo Clinic Proceedings, 1996, 71, 1, 69

    CrossRef

  45. 45
    J. M. Kremer, Methotrexate Update, Scandinavian Journal of Rheumatology, 1996, 25, 6, 341

    CrossRef

  46. 46
    Bruce N. Cronstein, Molecular therapeutics. Methotrexate and its mechanism of action, Arthritis & Rheumatism, 1996, 39, 12
  47. 47
    A. Schnabel, K. Dalhoff, S. Bauerfeind, J. Barth, W. L. Gross, Sustained cough in methotrexate therapy for rheumatoid arthritis, Clinical Rheumatology, 1996, 15, 3, 277

    CrossRef

  48. 48
    Michael J. Ahern, Geetha Chandran, Category III Symptom-Modifying Antirheumatic Drugs, Clinical Immunotherapeutics, 1995, 3, 3, 196

    CrossRef

  49. 49
    Methotrexate for Chronic Diseases in Adults, New England Journal of Medicine, 1995, 332, 26, 1791

    CrossRef

  50. 50
    Sarah L. Morgan, Joseph E. Baggott, Graciela S. , Mph, Alarcón Facp, William J. Koopman, Carlos L. Krumdieck, Leucovorin Versus Folic Acid in the Treatment of Methotrexate Toxicity: Comment on the Article by Shiroky et a1, Arthritis & Rheumatism, 1994, 37, 3
  51. 51
    Anthony Markham, Diana Faulds, Methotrexate, Clinical Immunotherapeutics, 1994, 1, 3, 217

    CrossRef

  52. 52
    Alastair J.J. Wood, Joseph M. Cash, John H. Klippel, Second-Line Drug Therapy for Rheumatoid Arthritis, New England Journal of Medicine, 1994, 330, 19, 1368

    CrossRef

  53. 53
    Zulma Ortiz, Beverley Shea, Maria E Suarez-Almazor, David Moher, George A Wells, Peter Tugwell, Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis, The Cochrane Library,
  54. 54
    Beverley Shea, Michael V Swinden, Elizabeth Tanjong Ghogomu, Zulma Ortiz, Wanruchada Katchamart, Tamara Rader, Claire Bombardier, George A Wells, Peter Tugwell, Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis, The Cochrane Library,